PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine-DIMED, University of Padua, Italy; Department of Laboratory Medicine, University-Hospital of Padua, Italy.\', \'Department of Laboratory Medicine, University-Hospital of Padua, Italy.\', \'Laboratory of Experimental Animal Models, Division of Comparative Biomedical Sciences, Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro, Italy.\', \'Emergency Department, Padua University Hospital, Padua, Italy.\', \'Infective and Tropical Disease Unit, Padua University Hospital, Padua, Italy.\', \'Department of Surgical Oncological and Gastroenterological Sciences - DISCOG, University of Padua, Italy; Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.\', \'Department of Medicine-DIMED, University of Padua, Italy; Department of Laboratory Medicine, University-Hospital of Padua, Italy. Electronic address: mario.plebani@unipd.it.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0009-8981(21)00372-710.1016/j.cca.2021.10.028
?:hasPublicationType
?:journal
  • Clinica chimica acta; international journal of clinical chemistry
is ?:pmid of
?:pmid
?:pmid
  • 34755646
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • SARS-CoV-2 neutralizing antibodies after one or two doses of Comirnaty (BNT162b2, BioNTech/Pfizer): Kinetics and comparison with chemiluminescent assays.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34755646>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34755646>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all